biote Corp.
OTC:BTMD
3.78 (USD) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 48.992 | 49.834 | 51.384 | 49.169 | 46.804 | 45.703 | 45.557 | 49.257 | 44.843 | 44.485 | 41.97 | 41.359 | 37.143 | 37.536 | 35.567 | 34.75 | 31.543 | 30.831 |
| Cost of Revenue
| 12.61 | 14.304 | 15.172 | 15.287 | 14.117 | 15.515 | 14.167 | 15.828 | 13.877 | 15.424 | 13.337 | 13.537 | 12.277 | 13.526 | 12.29 | 11.64 | 11.361 | 11.303 |
| Gross Profit
| 36.382 | 35.53 | 36.212 | 33.882 | 32.687 | 30.188 | 31.39 | 33.429 | 30.966 | 29.061 | 28.633 | 27.822 | 24.866 | 24.01 | 23.277 | 23.11 | 20.182 | 19.528 |
| Gross Profit Ratio
| 0.743 | 0.713 | 0.705 | 0.689 | 0.698 | 0.661 | 0.689 | 0.679 | 0.691 | 0.653 | 0.682 | 0.673 | 0.669 | 0.64 | 0.654 | 0.665 | 0.64 | 0.633 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 48.845 | 0 | 25.76 | 23.085 | 20.296 | 19.612 | 111.948 | 13.646 | 15.953 | 12.311 | 11.327 | 9.463 | 8.082 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | -28.726 | 0 | 0 | 0 | 1.276 | 0.997 | 1.114 | 1.241 | 1.683 | 1.417 | 1.059 | 1.326 | 1.417 |
| SG&A
| 26.692 | 32.763 | 24.028 | 27.649 | 22.26 | 20.119 | 23.791 | 25.76 | 23.085 | 21.572 | 20.609 | 113.062 | 14.887 | 17.636 | 13.728 | 12.386 | 10.789 | 9.499 |
| Other Expenses
| 0 | 0 | 0 | 0 | -0.002 | -0.002 | -0.003 | 0.898 | 0 | 0.186 | 0.209 | 0.363 | 0.216 | 0.004 | 0.005 | 0.004 | -0.03 | 0 |
| Operating Expenses
| 26.692 | 33.513 | 24.028 | 27.649 | 22.26 | 20.119 | 23.791 | 25.76 | 23.085 | 21.758 | 20.818 | 113.425 | 15.103 | 18.085 | 14.294 | 12.85 | 10.785 | 9.5 |
| Operating Income
| 9.69 | 2.767 | 12.184 | 6.233 | 10.427 | 10.069 | 7.599 | 7.669 | 7.881 | 7.303 | 7.815 | -85.603 | 9.763 | 5.925 | 8.983 | 10.26 | 9.393 | 10.029 |
| Operating Income Ratio
| 0.198 | 0.056 | 0.237 | 0.127 | 0.223 | 0.22 | 0.167 | 0.156 | 0.176 | 0.164 | 0.186 | -2.07 | 0.263 | 0.158 | 0.253 | 0.295 | 0.298 | 0.325 |
| Total Other Income Expenses Net
| 7.765 | -3.987 | 3.671 | -16.528 | -13.751 | 3.826 | 15.917 | -19.842 | -28.681 | 5.942 | -7.087 | 63.928 | -0.349 | -0.368 | -0.379 | -0.421 | -0.488 | -0.505 |
| Income Before Tax
| 17.455 | -1.22 | 15.855 | -10.295 | -3.324 | 9.334 | 23.516 | -12.173 | -20.8 | 13.245 | -6.112 | 39.995 | 9.414 | 5.557 | 8.604 | 9.839 | 8.905 | 9.524 |
| Income Before Tax Ratio
| 0.356 | -0.024 | 0.309 | -0.209 | -0.071 | 0.204 | 0.516 | -0.247 | -0.464 | 0.298 | -0.146 | 0.967 | 0.253 | 0.148 | 0.242 | 0.283 | 0.282 | 0.309 |
| Income Tax Expense
| 1.616 | -4.703 | 3.198 | 0.18 | 2.486 | -2.744 | 3.874 | 0.922 | 0.63 | 0.436 | 0.234 | -0.346 | 0.064 | 0.077 | 0.067 | 0.078 | 0.064 | 0.07 |
| Net Income
| 13.718 | 3.703 | 10.702 | -6.322 | -2.07 | 7.734 | 7.53 | -5.143 | -6.805 | 12.809 | -6.346 | 49.71 | 9.35 | 5.48 | 8.537 | 9.761 | 8.841 | 9.454 |
| Net Income Ratio
| 0.28 | 0.074 | 0.208 | -0.129 | -0.044 | 0.169 | 0.165 | -0.104 | -0.152 | 0.288 | -0.151 | 1.202 | 0.252 | 0.146 | 0.24 | 0.281 | 0.28 | 0.307 |
| EPS
| 0.44 | 0.12 | 0.34 | -0.19 | -0.06 | 0.23 | 0.25 | -0.25 | -0.39 | 1.47 | -0.83 | 6.56 | 1.23 | 0.72 | 1.13 | 1.29 | 9.02 | 9.65 |
| EPS Diluted
| 0.37 | 0.099 | 0.33 | -0.19 | -0.06 | 0.12 | 0.24 | -0.25 | -0.39 | 0.22 | -0.83 | 6.56 | 1.23 | 0.72 | 1.13 | 1.29 | 9.02 | 9.65 |
| EBITDA
| 9.69 | 3.14 | 12.184 | -6.842 | -0.914 | 12.386 | 25.462 | -9.028 | -18.616 | 7.922 | 3.122 | -20.319 | 10.275 | 5.929 | 9.376 | 10.597 | 9.568 | 10.139 |
| EBITDA Ratio
| 0.198 | 0.063 | 0.237 | -0.139 | -0.02 | 0.271 | 0.559 | -0.183 | -0.415 | 0.178 | 0.074 | -0.491 | 0.277 | 0.158 | 0.264 | 0.305 | 0.303 | 0.329 |